Announcement on Convening Investor Briefing on Major Asset Restructuring Matters
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Convening Investor Briefing on Major Asset Restructuring Matters
Filed with SSE · · 2 pages · Chinese
On 6ix: 6ix.com/news/announcement-on-convening-investor-briefing-on-major-asset-restructuring-matters-2
Release
Beijing Sun-Novo Pharmaceutical Research Co. Ltd. on 6ix
Earlier from Beijing Sun-Novo Pharmaceutical Research
- Announcement on Voluntary Disclosure of Obtaining Notice of Approval for Clinical Trials of BTP4507
- Voluntary Announcement on Extension of Affiliated Company's Plan to Purchase the Company's Shares
- Indicative Announcement on Equity Change by Controlling Shareholder and Persons Acting in Concert
- Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2025
- 2025 Semi-annual Report
Later from Beijing Sun-Novo Pharmaceutical Research
- Announcement on Postponing the 4th Extraordinary General Meeting in 2025
- Announcement on Postponing the 4th Extraordinary General Meeting in 2025 for Another Time
- Announcement on Resolutions of the 24th Meeting of the 2nd Board of Directors
- Announcement on Convening the Q3 2025 Performance Briefing
- Announcement on Resolutions of the 26th Meeting of the 2nd Board of Directors
Follow Beijing Sun-Novo Pharmaceutical Research into a list and get an email when it puts out news.
Follow Beijing Sun-Novo Pharmaceutical Research